List view / Grid view
13 July 2016 | By Victoria White, Digital Content Producer
Preclinical studies have shown that cancer drug nilotinib may protect neuronal cells from Parkinson's pathology by inhibiting the activity of c-Abl...
13 July 2016 | By Victoria White, Digital Content Producer
Prevnar 13 is now approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by S. pneumoniae...
12 July 2016 | By Biopharma Group
Polymorph screening is an important stage of drug development. The aim is to identify the different crystalline structures or polymorphs that a drug may appropriate...
12 July 2016 | By Victoria White, Digital Content Producer
Certolizumab pegol is recommended as an option for people with severe rheumatoid arthritis when other drugs haven’t worked or aren’t suitable...
12 July 2016 | By Victoria White, Digital Content Producer
The Phase I trial will evaluate the safety of intramuscular injections of PLX-R18 cells in 30 patients with incomplete haematopoietic recovery...
12 July 2016 | By Victoria White, Digital Content Producer
With this approval, Xiidra is the only prescription eye drop indicated for the treatment of both signs and symptoms of this condition...
11 July 2016 | By Victoria White, Digital Content Producer
The SMC has accepted five new medicines for routine use in NHS Scotland including lung cancer treatments nivolumab and crizotinib...
11 July 2016 | By Victoria White, Digital Content Producer
This license agreement opens new markets to Celyad and expands the global footprint of its NKR-2 T-cell cancer immunotherapy treatment...
11 July 2016 | By Victoria White, Digital Content Producer
The FDA has approved Genentech’s Xolair (omalizumab) to treat moderate to severe persistent asthma in children six to 11 years of age...
11 July 2016 | By Victoria White, Digital Content Producer
If approved, RVT-101 could be the first Alzheimer’s treatment in 14 years. The last drug to be approved to help improve cognition was Donepezil in 2002...
11 July 2016 | By Victoria White, Digital Content Producer
Viridian Pharma has developed five products that have regulatory approval in the UK and represent first-to-market specialty hospital-prescribed medicines...
8 July 2016 | By Victoria White, Digital Content Producer
The S-TRAC study of Sutent versus placebo in the adjuvant setting met its primary endpoint of improving disease-free survival in renal cell carcinoma...
8 July 2016 | By Victoria White, Digital Content Producer
Eisai has expressed concern that patients in England and Wales will have to wait three years to access Lenvatinib due to a ‘black hole’ in the CDF process...
8 July 2016 | By CPhI
CPhI Korea is experiencing a huge surge in interest; with over 5000 pharma professionals envisaged to converge at the COEX centre during the three-day event...
7 July 2016 | By Victoria White, Digital Content Producer
This important decision allows reimbursed access to Translarna, the first approved therapy to treat the underlying cause of Duchenne muscular dystrophy...
